KRAS and non-small cell lung carcinoma: The remaining 5 cases exhibited mutations in: EGFR, insulin-like growth factor receptor (IGF1R), cellular-mesenchymal to epithelial transition factor (c-MET), PIK3CA, and Kirsten rat’s arcomaviral oncogene (KRAS) in NSCLC part.